Teacher Retirement System of Texas Purchases 6,925 Shares of Hims & Hers Health, Inc. $HIMS

Teacher Retirement System of Texas boosted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 26.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,018 shares of the company’s stock after purchasing an additional 6,925 shares during the quarter. Teacher Retirement System of Texas’ holdings in Hims & Hers Health were worth $1,646,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Bessemer Group Inc. boosted its position in Hims & Hers Health by 105.8% during the second quarter. Bessemer Group Inc. now owns 607 shares of the company’s stock valued at $30,000 after purchasing an additional 312 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in Hims & Hers Health during the first quarter valued at about $30,000. BI Asset Management Fondsmaeglerselskab A S bought a new stake in Hims & Hers Health during the first quarter valued at about $41,000. Larson Financial Group LLC boosted its position in Hims & Hers Health by 47.7% during the first quarter. Larson Financial Group LLC now owns 1,419 shares of the company’s stock valued at $42,000 after purchasing an additional 458 shares in the last quarter. Finally, Webster Bank N. A. boosted its position in Hims & Hers Health by 229.1% during the second quarter. Webster Bank N. A. now owns 905 shares of the company’s stock valued at $45,000 after purchasing an additional 630 shares in the last quarter. Institutional investors own 63.52% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the company. KeyCorp assumed coverage on Hims & Hers Health in a research note on Tuesday, October 21st. They issued a “sector weight” rating for the company. Canaccord Genuity Group reiterated a “buy” rating and issued a $68.00 price target on shares of Hims & Hers Health in a research note on Friday, September 12th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Hims & Hers Health in a research note on Tuesday, October 14th. Wall Street Zen cut Hims & Hers Health from a “buy” rating to a “hold” rating in a research note on Monday, July 28th. Finally, Bank of America increased their price target on Hims & Hers Health from $28.00 to $32.00 and gave the company an “underperform” rating in a research note on Tuesday. Two research analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average target price of $43.75.

Insider Transactions at Hims & Hers Health

In other Hims & Hers Health news, CFO Oluyemi Okupe sold 11,592 shares of the business’s stock in a transaction on Friday, October 17th. The stock was sold at an average price of $57.13, for a total transaction of $662,250.96. Following the transaction, the chief financial officer owned 70,232 shares of the company’s stock, valued at approximately $4,012,354.16. The trade was a 14.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Soleil Boughton sold 2,637 shares of the business’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $50.10, for a total value of $132,113.70. Following the transaction, the insider directly owned 158,493 shares in the company, valued at $7,940,499.30. This trade represents a 1.64% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,372,271 shares of company stock valued at $71,014,785 over the last ninety days. Company insiders own 17.71% of the company’s stock.

Hims & Hers Health Stock Down 3.9%

Shares of HIMS stock opened at $42.67 on Wednesday. The stock has a 50 day moving average of $51.36 and a 200 day moving average of $50.84. The company has a current ratio of 4.98, a quick ratio of 4.46 and a debt-to-equity ratio of 1.72. The stock has a market cap of $9.64 billion, a P/E ratio of 79.02, a P/E/G ratio of 3.07 and a beta of 2.20. Hims & Hers Health, Inc. has a twelve month low of $19.15 and a twelve month high of $72.98.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.09 EPS for the quarter, meeting the consensus estimate of $0.09. Hims & Hers Health had a return on equity of 26.48% and a net margin of 6.05%.The company had revenue of $598.98 million for the quarter, compared to analyst estimates of $578.99 million. During the same period last year, the company earned $0.32 earnings per share. Hims & Hers Health’s quarterly revenue was up 49.2% compared to the same quarter last year. Hims & Hers Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, sell-side analysts expect that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.